Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSPO | P30536 | 1/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 7/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
| ▸ | BTK | Q06187 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16511361 | 0.86 | TSPO (0.36) | TSPOPTGER4 | |
| SCHEMBL17122335 | 0.85 | L3MBTL1 (0.45) | TSPOPTGER4KDM4EATML3MBTL1 | |
| SCHEMBL30570842 | 0.85 | L3MBTL1 (0.45) | TSPOPTGER4KDM4EATML3MBTL1 | |
| SCHEMBL10307134 | 0.85 | L3MBTL1 (0.45) | TSPOPTGER4KDM4EATML3MBTL1 | |
| SCHEMBL16500926 | 0.85 | L3MBTL1 (0.45) | TSPOPTGER4KDM4EATML3MBTL1 | |
| SCHEMBL17122324 | 0.85 | L3MBTL1 (0.45) | TSPOPTGER4KDM4EATML3MBTL1 | |
| SCHEMBL17122337 | 0.85 | L3MBTL1 (0.45) | TSPOPTGER4KDM4EATML3MBTL1 | |
| SCHEMBL17122329 | 0.85 | L3MBTL1 (0.45) | TSPOPTGER4KDM4EATML3MBTL1 | |
| SCHEMBL17122320 | 0.85 | L3MBTL1 (0.45) | TSPOPTGER4KDM4EATML3MBTL1 | |
| SCHEMBL10307144 | 0.85 | L3MBTL1 (0.45) | TSPOPTGER4KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110297924-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2011-12-08 | — | — | US | disclosed |
| US-20110297924-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2011-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110297924-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | SLC18A2, SLC18A1, SLC7A5 | TSPO 798/4885PTGER4 3882/4885KDM4E 214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.